Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013052 · ClinicalTrials.gov registry record · NA

Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
2,068
Enrollment target

NCT00013052: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00013052 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 2,068 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013052, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
2,068 participants
Enrollment target

Study Summary

Control of the blood sugar prevents complications and results in extra years of life in patients with diabetes. Practice Guidelines delineating specific ways physicians manage diabetes have been outlined. Missing are guidelines for health care providers to encourage patients to take responsibility for their diabetes. Traditional patient education models have been ineffective in managing diabetic persons because they have relied upon information given alone and are disease centered rather than patient centered. This study will explore the role of self-efficacy in helping veterans move toward healthy behaviors.

Interventions

  • BEHAVIORAL Peer led classes. Led by trained veterans with a chronic disease.

Trial Details

FieldValue
Enrollment Target 2,068 participants
Est. Completion 2002-09
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00013052 record still lists

NCT00013052 is an interventional study that assigns participants to a tested intervention. Its 2,068 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher).

The record links to 0 conditions, and to 1 intervention - of which Peer led classes. Led by trained veterans with a chronic disease. is the first listed.

NCT00013052 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00013052 about?

NCT00013052 is a clinical study titled "Improving Health Outcomes of Diabetic Veterans: A Diabetic Self-Management Program". Control of the blood sugar prevents complications and results in extra years of life in patients with diabetes. Practice Guidelines delineating specific ways physicians manage diabetes have been outlined. Missing are guidelines for health care providers to encourage patients to take responsibility f...

What is the current status of trial NCT00013052?

This trial is currently completed. It is a NA study. The enrollment target is 2,068 participants. Estimated completion is 2002-09.

What interventions are being tested in trial NCT00013052?

The interventions under investigation include: Peer led classes. Led by trained veterans with a chronic disease. (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013052?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00013052's enrollment target sits among peer trials

2,068 50th of 2000 higher than 1,951 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06666192 · 2,067 participants · NA

    The Ohio State University (OSU) SCREEN Community Program

  • NCT00588068 · 2,070 participants

    Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

  • NCT07168993 · 2,063 participants · NA

    Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

  • NCT04871542 · 2,062 participants

    Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Source: ClinicalTrials.gov NCT00013052, the US trial registry maintained by the National Library of Medicine. NCT00013052 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.